Managing multiple Claude Code projects doesn't have to be chaotic. My iTerm2 setup dramatically reduces friction in my daily ...

As I write this, four astronauts are on their way around the moon for the first time in 50 years. A lot us have asked ...

This will take a few minutes. Attention: the generated file has a size of approx. 12 GB, so make sure to have enough diskspace. If you're running the challenge with a non-Java language, there's a ...

In Moalboal (top right), visitors experience a different thrill with the sardine run off Panagsama Beach TAGBILARAN CITY. Bohol— The Cebu provincial government has turned over the implementation of ...

The company will continue to distribute library content, but will end production of first-run syndicated programming in a strategic shift. By Alex Weprin Senior Editor “NBCUniversal is making changes ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

CHARLESTON — A nonprofit run by City Councilman Aaron Polkey, who was sworn in last month, is set to receive nearly $240,000 from the city for a homeless program. Polkey, president and CEO of Palmetto ...

Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...

TURKU, Finland, Feb. 10, 2026 /PRNewswire/ -- Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that ...

Hey there, fellow coder! 😊 Ever typed java -version in your Command Prompt only to be hit with a frustrating "java is not recognized as an internal or external command"? You're not alone—this common ...

Chinese state-sponsored threat actors were likely behind the hijacking of Notepad++ update traffic last year that lasted for almost half a year, the developer states in an official announcement today.

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.